Table 2.
Overview of the hepatic differentiation timeline, the final concentration of growth factors and small molecules used
| Day | Cell type | Final concentration of growth factors and small molecules |
|---|---|---|
| D-2 | hPSCs | N/A |
| D-1 | N/A | |
| D0 | hPSCs | Activin A 100 ng/mL + CHIR99021 3 μM + LY294002 10 μM |
| D1 | N/A | |
| D2 | N/A | |
| D3 | Definitive Endoderm |
Activin A 50 ng/mL |
| D4 | N/A | |
| D5 | Anterior Definitive Endoderm |
Activin A 50 ng/mL |
| D6 | BMP4 20 ng/mL + FGF10 10 ng/mL | |
| D7 | BMP4 20 ng/mL + FGF10 10 ng/mL | |
| D8 | N/A | |
| D9 | Hepatoblasts | BMP4 20 ng/mL + FGF10 10 ng/mL |
| D10 | OSM 30 ng/mL + HGF 50 ng/mL | |
| D11 | N/A | |
| D12 | OSM 30 ng/mL + HGF 50 ng/mL | |
| D13 | N/A | |
| D14 | OSM 30 ng/mL + HGF 50 ng/mL | |
| D15 | N/A | |
| D16 | OSM 30 ng/mL + HGF 50 ng/mL | |
| D17 | N/A | |
| D18 | OSM 30 ng/mL + HGF 50 ng/mL | |
| D19 | N/A | |
| D20 | OSM 30 ng/mL + HGF 50 ng/mL | |
| D21 | N/A | |
| D22 | OSM 30 ng/mL + HGF 50 ng/mL | |
| D23 | N/A | |
| D24 | Hepatocyte-like cells | OSM 30 ng/mL + HGF 50 ng/mL |